Group items tagged

The top five players in the global optical imaging market accounted for over 80% of the market share. However, the intense competition by existing small- and mid-sized players in the market is threatening the market share of top players. In order to maintain their share, leading players are continuously embracing new technologies and striving to bring advanced products into the market. This increasing competitiveness is also expected to drive innovation in the market, thereby helping the industry to solve existing challenges and meet the needs of the market.

The report extensively covers the healthcare provider IT and payer IT markets. The market in this report has been segmented on the basis of its applications, delivery modes, and components. Based on applications, the healthcare information technology is segmented into provider (clinical information technology and non-clinical information technology) and payer, while the market by delivery mode is further categorized as on-premises, web-based, and cloud-based.

The global cell counting market is mainly dominated by six players that accounted for around 65% to 70% of the global market share in 2014. However, new players in the market are intensifying competition and thereby threatening the market share of the existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve the existing challenges.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

As of 2014, Agilent Technologies, Inc. (U.S.) held the leadership position in the global market. Over the past three years, the company adopted new product launches and strategic acquisitions as its key business strategies to ensure its dominant position in this market. In addition, TE Connectivity Ltd. (Switzerland), Danaher Corporation (U.S.), E.S.I. Environment Sensors Inc. (Canada), Honeywell International, Inc. (U.S.), Lockheed Martin Corporation (U.S.), Ball Aerospace and Technologies Corporation (U.S.), The Raytheon Company (U.S.), Siemens AG (Germany), and Thales Group (France) are some of the other key players in this market.

The veterinary software market by product type is divided into practice management software and veterinary imaging software. The veterinary practice management software helps veterinarians in appointment management, billing & invoicing, boarding management, patient records, prescription labeling, reminders, and treatment management. The veterinary imaging segment includes standalone digital imaging software used for X-ray CT, MRI, ultrasound and other digital imaging in clinics/ hospitals and laboratories.